Moreover, AGO2-mutated KRAS interaction holds crucial importance in pancreatic ductal adenocarcinoma progression, where AGO2 expression is required for overcoming oncogene-induced senescence and cancer development [29]. The gene discussed is AGO2; the disease is pancreatic ductal adenocarcinoma.